Author: Bottiroli, Maurizio; De Caria, Daniele; Belli, Oriana; Calini, Angelo; Andreoni, Patrizia; Siragusa, Antonio; Moreo, Antonella; Ammirati, Enrico; Mondino, Michele; Fumagalli, Roberto
Title: Takotsubo syndrome as a complication in a critically ill COVIDâ€19 patient Cord-id: c5ykedzq Document date: 2020_9_4
ID: c5ykedzq
Snippet: Coronavirus disease 2019 (COVIDâ€19) patients with cardiac injury have an increased risk of mortality. It remains to be determined the mechanism of cardiac injury and the identification of specific conditions that affect the heart during COVIDâ€19. We present the case of a 76â€yearâ€old woman with COVIDâ€19 pneumonia that developed a takotsubo syndrome (TTS). Although the patient presented normal left ventricular ejection fraction and normal levels of troponin on admission, after 16 days in
Document: Coronavirus disease 2019 (COVIDâ€19) patients with cardiac injury have an increased risk of mortality. It remains to be determined the mechanism of cardiac injury and the identification of specific conditions that affect the heart during COVIDâ€19. We present the case of a 76â€yearâ€old woman with COVIDâ€19 pneumonia that developed a takotsubo syndrome (TTS). Although the patient presented normal left ventricular ejection fraction and normal levels of troponin on admission, after 16 days in intensive care unit due to respiratory distress, she suddenly developed cardiogenic shock. Shock occurred few hours after a spontaneous breathing trial through her tracheostomy. Bedâ€side echocardiographic revealed apical ballooning promptly supporting the diagnosis of TTS. She was successfully treated with deep sedation and low dosage of epinephrine. The relevance of this case is that TTS can occur in the late phase of COVIDâ€19. Awareness of late TTS and bedâ€side echocardiographic evaluation can lead to prompt identification and treatment.
Search related documents:
Co phrase search for related documents- absence patient and acute kidney injury: 1
- absence patient and acute respiratory coronavirus: 1, 2, 3, 4
- absence patient and acute respiratory distress syndrome: 1, 2
- acid testing and acute increase: 1
- acid testing and acute kidney injury: 1, 2
- acid testing and acute onset: 1, 2, 3
- acid testing and acute respiratory coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acid testing and acute respiratory distress syndrome: 1
- acid testing and lopinavir ritonavir: 1, 2, 3, 4
- acute coronary syndrome and lopinavir ritonavir: 1, 2
- acute kidney injury and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
- acute myocarditis and lopinavir ritonavir: 1, 2, 3
- acute myocarditis and lv ejection fraction: 1, 2, 3, 4, 5
- acute myocarditis and lv left ventricular: 1, 2, 3, 4, 5, 6, 7, 8
- acute onset and lopinavir ritonavir: 1, 2, 3
- acute respiratory coronavirus and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory coronavirus and lv ejection fraction: 1, 2
- acute respiratory distress syndrome and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- lopinavir ritonavir and lv ejection fraction: 1
Co phrase search for related documents, hyperlinks ordered by date